Gilead Sciences, Inc. (GILD)
146.76
+0.64
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
146.50
-0.26
(-0.18%)
After-Hours: 20:00
Gilead Sciences 1 Year Total Returns (Daily) : 29.10% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 29.10% |
| August 20, 2026 | 23.97% |
| August 19, 2026 | 28.37% |
| August 18, 2026 | 24.74% |
| August 17, 2026 | 20.43% |
| August 14, 2026 | 19.29% |
| August 13, 2026 | 17.99% |
| August 12, 2026 | 16.16% |
| August 11, 2026 | 15.64% |
| August 10, 2026 | 14.34% |
| August 07, 2026 | 23.95% |
| August 06, 2026 | 21.76% |
| August 05, 2026 | 20.22% |
| August 04, 2026 | 21.20% |
| August 03, 2026 | 18.90% |
| July 31, 2026 | 18.99% |
| July 30, 2026 | 17.38% |
| July 29, 2026 | 19.23% |
| July 28, 2026 | 21.94% |
| July 27, 2026 | 15.26% |
| July 24, 2026 | 17.22% |
| July 23, 2026 | 18.24% |
| July 22, 2026 | 21.40% |
| July 21, 2026 | 23.46% |
| July 20, 2026 | 26.31% |
| Date | Value |
|---|---|
| July 17, 2026 | 26.64% |
| July 16, 2026 | 27.32% |
| July 15, 2026 | 23.91% |
| July 14, 2026 | 19.04% |
| July 13, 2026 | 22.98% |
| July 10, 2026 | 16.31% |
| July 09, 2026 | 22.18% |
| July 08, 2026 | 25.49% |
| July 07, 2026 | 25.18% |
| July 06, 2026 | 19.01% |
| July 02, 2026 | 20.80% |
| July 01, 2026 | 15.69% |
| June 30, 2026 | 16.93% |
| June 29, 2026 | 17.13% |
| June 26, 2026 | 21.93% |
| June 25, 2026 | 19.96% |
| June 24, 2026 | 19.80% |
| June 23, 2026 | 20.84% |
| June 22, 2026 | 18.09% |
| June 18, 2026 | 17.59% |
| June 17, 2026 | 19.19% |
| June 16, 2026 | 17.80% |
| June 15, 2026 | 15.97% |
| June 12, 2026 | 15.08% |
| June 11, 2026 | 18.24% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals, Inc. | 37.89% |
| AbbVie, Inc. | 30.40% |
| Regeneron Pharmaceuticals, Inc. | 40.13% |
| Amgen, Inc. | 53.88% |
| Biogen, Inc. | 55.82% |